FOFFANO, LORENZO
 Distribuzione geografica
Continente #
AS - Asia 77
EU - Europa 65
NA - Nord America 27
SA - Sud America 18
Totale 187
Nazione #
IT - Italia 37
SG - Singapore 34
US - Stati Uniti d'America 24
CN - Cina 18
HK - Hong Kong 16
BR - Brasile 14
DE - Germania 7
FR - Francia 6
KR - Corea 6
AT - Austria 4
RU - Federazione Russa 4
AR - Argentina 2
FI - Finlandia 2
IE - Irlanda 2
MX - Messico 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BO - Bolivia 1
CA - Canada 1
DK - Danimarca 1
GB - Regno Unito 1
NL - Olanda 1
PE - Perù 1
TR - Turchia 1
Totale 187
Città #
Singapore 24
Hong Kong 16
Arezzo 8
Hefei 6
Seoul 6
Beijing 5
Trieste 5
Belluno 4
Milan 4
Venice 3
Dublin 2
Düsseldorf 2
Frankfurt am Main 2
Guangzhou 2
Los Angeles 2
Mexico City 2
Mirano 2
Porcia 2
Roccamonfina 2
Santa Clara 2
Turku 2
Vienna 2
Wenzhou 2
Acaraú 1
Afonso Cláudio 1
Ankara 1
Ashburn 1
Berlin 1
Boardman 1
Brooklyn 1
Buenos Aires 1
Campo Grande 1
Caorle 1
Deiva Marina 1
Genoa 1
Guaraciaba do Norte 1
Helena 1
Huntington Beach 1
Jequié 1
Kabul 1
Lauterbourg 1
Leopoldina 1
Lima region 1
London 1
Macedônia 1
Mansfield 1
New York 1
Nuremberg 1
Padova 1
Paris 1
Phoenix 1
Rockville 1
San Juan 1
Santa Cruz 1
Santa Cruz Cabrália 1
Santa Luzia 1
Santa Maria 1
Senador Firmino 1
São Vicente 1
Teutônia 1
Volta Redonda 1
Yerevan 1
Totale 146
Nome #
Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer? 67
Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling 30
Beyond Hormone Receptors: liquid biopsy tools to unveil new clinical meanings and empower therapeutic decision-making in Luminal-like metastatic breast cancer 25
Hallmarks of Appetite: A Comprehensive Review of Hunger, Appetite, Satiation, and Satiety 24
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find them 21
Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer 21
Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches 20
Totale 208
Categoria #
all - tutte 664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 664


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20243 0 0 0 0 0 0 0 0 0 0 0 3
2024/2025205 18 3 9 0 3 2 18 20 41 23 32 36
Totale 208